MLF数字营销平台

Home >Medicine & equipment >medicine

腺苷蛋氨酸

Price
Negotiable
Unit
KG
Product number
201711220823356295
Place of Origin
中国 - 山东 - 淄博
  • Product introduction
  • Function:0
    Theory:0
    Application Area:0
    Product Characteristics:0


    【产品名称】腺苷蛋氨酸

    【含量】98.0%-101.0%

    【质量规格】EP,USP

    【储存】遮光,密封保存

    【外观】白色结晶性粉末

    图片关键词

     

    外观:白色结晶体粉末

    含量:98.0%-101.0%

    质量规格:EP,USP

    储存:遮光,密封保存

     

    图片关键词

     

    对甲苯磺酸腺苷蛋氨酸

    用于口服营养品

    1,4-丁二磺酸腺苷蛋氨酸

    CAS No:101020-79-5

    用于注射级/无菌冻干粉

     

    图片关键词

     

    腺苷蛋氨酸具有转甲基、转安丙基和转硫等多种生理作用,是一种重要的生理活性物质,对维护人体健康发挥着重要作用。常用剂型有冻干粉针、片剂、胶囊剂等。

    产品主要功能

    ● 改善情绪

    腺苷蛋氨酸可以加强大脑多巴胺和5-羚色胺神经递质代谢和信息传递功能。对于治疗抑郁症,比目前常用的药物效果好,无依赖性,毒副作用轻微。

    ● 肝脏疾病

    腺苷蛋氨酸对病毒性肝炎、胆汁郁积、酒精肝,包括肝硬化及其他一些肝功能紊乱都有非常好的疗效。

    ● 骨关节健康

    腺苷蛋氨酸能够减轻疼痛和改善关节功能

    ● 辅助治疗冠心病

    Auxiliary  treatment  for Coronary heart disease (CHD)

  • Company Name
    Shandong Jincheng Pharmaceutical Group Co., Ltd.
    Place of Origin
    中国 - 山东 - 淄博

      Shandong Jincheng Pharmaceutical Group Co., Ltd.  (Hereafter named as”JINCHENG PHARM”, Stock code: 300233) was established in 2004 and successful launched in Shenzhen GEM Board on June, 2011. The company is honored as National High-New Technology Enterprise. It has three whole owned subsidiary companies—Shandong Jincheng Kerui Chemical Co.,Ltd., Shandong Huihai Pharmaceutical and Chemical Co.,Ltd. ,Shandong Jincheng Zhonghua Bio-Pharmaceutical Co.,Ltd. and four production bases.The company is dedicated to research and development, production and sales for III、IV Cephalosporin intermediates. In this field, the company has great advantage and established Post-Doctoral Scientific Research station and Enterprise Technical Center of Shandong Province. The company is one of the main suppliers who own obvious competitive advantage for cephalosporin intermediates in the world market. Moreover, the company has formed the High-New technical products chain from basic chemicals to pharmaceutical intermediates and  extend to special APIs and biopharmaceuticals through actively practices the development pattern of “Change the development mode, Adjust the structure”, improve the independent innovation ability and adjusts and optimize the industrial structure.

Send your message to us: